Occupational Therapists in Shawnee Mission, KS Accepting Medicare

6 Occupational Therapists found. Showing 1 - 6

Erin Haniger, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St, 121, Shawnee Mission, KS 66204 Phone: 913-362-7518    Fax: 913-362-7302

Mrs. Darcey Klein, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518

Deborah A. King, M.a. And Assoc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10,000 West 75th, Suite 121, Shawnee Mission, KS 66204 Phone: 913-362-7518    Fax: 913-362-7302

Carrie Martin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518    Fax: 913-362-7302

Kathleen Malarkey Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Shawnee Mission, KS 66204 Phone: 913-362-7518    Fax: 913-362-7302

Kelli Almaria Johnson Occupational Therapist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 1000 West 75th Street, Shawnee Mission, KS 66204 Phone: 913-362-1669

News Archive

Omega-3 fatty acids for a health heart

While a heart-healthy diet has become synonymous with plenty of fruits and vegetables and little fat and cholesterol, there's more to the story. Omega-3 fatty acids should be part of a heart-healthy diet, too, according to the August issue of Mayo Clinic Health Letter.

Removal of ZIP proteins from hippocampus cell protects them from injury

Researchers in the Blue Bird Circle Developmental Neurogenetics Laboratory in the department of neurology at Baylor College of Medicine have discovered that zinc enters cells through specialized protein gates known as ZIP transporters, and removing these ZIP proteins from cells in the hippocampus significantly protects them from injury.

Investigational drug vericiguat benefits patients with worsening heart failure

Patients with worsening heart failure and reduced ejection fraction who received the investigational drug vericiguat had a significantly lower rate of cardiovascular death or heart failure hospitalization compared with those receiving a placebo, based on research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

Scientists receive funding to continue research into pathological processes supporting Alzheimer's

Neuroscientists at the University of Bristol have received a major funding boost of -550,000 from the Medical Research Council to continue their research into the pathological processes underpinning Alzheimer's disease, the most common cause of dementia, affecting around 465,000 people in the UK.

Read more Medical News

› Verified 5 days ago